OZEM

0.10% 0.0318

Vorhandelsmarkt: 30.50 -0.0152 -0.05%

Roundhill Glp 1 Weight Loss Etf (OZEM)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile

Roundhill Glp 1 Weight Loss Etf

Financial (5855)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OZEM's Discussions on Twitter

Compare OZEM vs VTI, SPY, IVV, VB, QQQ

Aktien	Preis	Marktkapitalisierung
OZEM Roundhill Glp 1 Weight Loss Etf	30.52	0
VTI Vanguard Total Stock Market Etf	365.76	417.53B
SPY Spdr S P 500 Etf Trust	740.96	372.57B
IVV Ishares Core S P 500 Etf	742.61	253.41B
VB Vanguard Small Cap Etf	293.07	160.59B
QQQ Invesco Qqq Trust Series 1	722.51	124.43B

Roundhill Glp 1 Weight Loss Etf Aktie (OZEM) Neueste Nachrichten

Finanzdaten der Roundhill Glp 1 Weight Loss Etf-Aktie (OZEM)

Es liegen keine Finanzdaten für Roundhill Glp 1 Weight Loss Etf (OZEM) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Roundhill Glp 1 Weight Loss Etf (OZEM)

Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile

Compare OZEM vs VTI, SPY, IVV, VB, QQQ

Roundhill Glp 1 Weight Loss Etf Aktie (OZEM) Neueste Nachrichten

Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Trends

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - The Globe and Mail

TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant - TradingView

GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - The Globe and Mail

485BPOS: Post-effective amendment - Moomoo

3 Ways to Invest in the Growing GLP-1 Weight Loss Market - MarketBeat

Stock List: Research Stocks from Around the World - GuruFocus

USA Stocks: Research Stocks from USA Stock Market - GuruFocus

OZEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

OZEM Stock Price, News & Analysis - Stock Titan

Can You Buy Ozempic Stock in 2026? - The Motley Fool

FDA Approves NVO's Increased Wegovy Dosage: Broaden Your Portfolio With These Healthcare ETFs - Bitget

FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - The Globe and Mail

Discipline and Rules-Based Execution in OZEM Response - Stock Traders Daily

Here are the quant ratings of OZEM’s top holdings amid Novo's selloff - MSN

OZEM stock: What the Ratings say (OZEM:NASDAQ) - Seeking Alpha

ETFs with Pfizer Inc. ( PFE ) Exposure - ETF Database

Behavioral Patterns of OZEM and Institutional Flows - Stock Traders Daily

Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Short Interest Up 47.1% in January - Defense World

How to Invest in GLP-1 Stocks in 2026 - The Motley Fool

(OZEM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - The Globe and Mail

NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit - intellectia.ai

OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha

EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most - Benzinga

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - MarketBeat

New Year, New Strategy: Navigating Weight Loss ETFs - ETF Database

Insiders Bullish on Certain Holdings of OZEM - Nasdaq

How Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Affects Rotational Strategy Timing - Stock Traders Daily

The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug - The Globe and Mail

6 Top-Performing ETF Areas of Last Week - sharewise.com

(OZEM) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Best-Performing ETFs of November - TradingView — Track All Markets

Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView

Eli Lilly Leads $150B Obesity Drug Race As Novo, Pfizer Battle; ETFs Poised To GainAbbVie (NYSE:ABBV) - Benzinga

Finanzdaten der Roundhill Glp 1 Weight Loss Etf-Aktie (OZEM)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie OZEM